China type 2 diabetes treatment status survey of treatment pattern of oral drugs users-Reference-Cited by-同舟云学术

China type 2 diabetes treatment status survey of treatment pattern of oral drugs users

Published:2014-08-07 Issue:2 Volume:7 Page:166-173
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Ji Linong¹,Lu Juming²,Weng Jianping³,Jia Weiping⁴,Tian Haoming⁵,Zhu Dalong⁶,Xing Xiaoping⁷,Guo Lixin⁸

Affiliation:

1. Department of Endocrinology; Peking University People's Hospital; Beijing China

2. Department of Endocrinology; Chinese PLA General Hospital; Beijing China

3. Department of Endocrinology; The Third Affiliated Hospital of Sun Yat-sen University; Guangzhou China

4. Department of Endocrinology; Shanghai 6th Hospital; Shanghai China

5. Department of Endocrinology; West China Hospital; Chengdu China

6. Department of Endocrinology; Nanjing Drum Tower Hospital; Nanjing China

7. Department of Endocrinology; Peking Union Medical College Hospital; Beijing China

8. Department of Endocrinology; Beijing Hospital; Beijing China

Funder

Novartis Pharma, Beijing, China

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010

2. Burden of diabetes in the adult Chinese population: A systematic literature review and future projections;Pan;Int J Gen Med,2010

3. Diabetes saps health and wealth from China's rise;Alcorn;Lancet,2012

4. Medical care and payment for diabetes in China: Enormous threat and great opportunity;Yang;PLoS One,2012

5. Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone;Zhang;Chin Med J (Engl),2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations Between Thiazolidinediones Use and Incidence of Rheumatoid Arthritis: A Retrospective Population‐Based Cohort Study;Arthritis Care & Research;2024-02

2. Risk factors and drug discovery for cognitive impairment in type 2 diabetes mellitus using artificial intelligence interpretation and graph neural networks;Frontiers in Endocrinology;2023-08-25

3. Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016–2018;Diabetes Research and Clinical Practice;2023-08

4. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach;International Journal of Diabetes in Developing Countries;2023-04-19

5. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30